FR26F - Medicinal product based on an amino oxazolinone derivative, intended, in particular, for the treatment of asthenia. - Google Patents

Medicinal product based on an amino oxazolinone derivative, intended, in particular, for the treatment of asthenia.

Info

Publication number
FR26F
FR26F FR885243A FR885243A FR26F FR 26 F FR26 F FR 26F FR 885243 A FR885243 A FR 885243A FR 885243 A FR885243 A FR 885243A FR 26 F FR26 F FR 26F
Authority
FR
France
Prior art keywords
asthenia
amino
treatment
intended
product based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR885243A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DAUSSE LAB
Original Assignee
DAUSSE LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR853826A external-priority patent/FR1438160A/en
Priority claimed from FR862555A external-priority patent/FR1243M/en
Application filed by DAUSSE LAB filed Critical DAUSSE LAB
Priority to FR885243A priority Critical patent/FR26F/en
Priority to CH205862A priority patent/CH412897A/en
Priority to DE1962L0041273 priority patent/DE1297108B/en
Priority to GB723362A priority patent/GB963375A/en
Priority to DK85062A priority patent/DK116058B/en
Application granted granted Critical
Publication of FR26F publication Critical patent/FR26F/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR885243A 1961-02-24 1962-01-18 Medicinal product based on an amino oxazolinone derivative, intended, in particular, for the treatment of asthenia. Expired FR26F (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR885243A FR26F (en) 1961-02-24 1962-01-18 Medicinal product based on an amino oxazolinone derivative, intended, in particular, for the treatment of asthenia.
CH205862A CH412897A (en) 1961-02-24 1962-02-19 Process for the preparation of amino oxazolinones
DE1962L0041273 DE1297108B (en) 1961-02-24 1962-02-20 2-AEthylamino-5-phenyl-oxazolone- (4) and process for its preparation
GB723362A GB963375A (en) 1961-02-24 1962-02-23 5-phenyl-2-ethylamino-4-oxazolinone and its preparation
DK85062A DK116058B (en) 1961-02-24 1962-02-23 Process for the preparation of 5-phenyl-2-ethylamino-oxazolinone- (4).

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR853826A FR1438160A (en) 1961-02-24 1961-02-24 Amino oxazolinones and ureas used in their preparation
FR862555A FR1243M (en) 1961-02-24 1961-05-23 Medicinal product based on an amino oxazolinone derivative intended, in particular, for the treatment of asthenia.
FR885243A FR26F (en) 1961-02-24 1962-01-18 Medicinal product based on an amino oxazolinone derivative, intended, in particular, for the treatment of asthenia.

Publications (1)

Publication Number Publication Date
FR26F true FR26F (en) 1963-04-05

Family

ID=27245877

Family Applications (1)

Application Number Title Priority Date Filing Date
FR885243A Expired FR26F (en) 1961-02-24 1962-01-18 Medicinal product based on an amino oxazolinone derivative, intended, in particular, for the treatment of asthenia.

Country Status (5)

Country Link
CH (1) CH412897A (en)
DE (1) DE1297108B (en)
DK (1) DK116058B (en)
FR (1) FR26F (en)
GB (1) GB963375A (en)

Also Published As

Publication number Publication date
CH412897A (en) 1966-05-15
DE1297108B (en) 1969-06-12
GB963375A (en) 1964-07-08
DK116058B (en) 1969-12-08

Similar Documents

Publication Publication Date Title
FR1916M (en) Medicinal product based on 16.α-methyl-6-α-fluoro-1.4-prégnadiene-11.β.21-diol-3.20-dione.
BE622943A (en) Therapeutic compositions, containing emetine derivatives.
FR1243M (en) Medicinal product based on an amino oxazolinone derivative intended, in particular, for the treatment of asthenia.
FR26F (en) Medicinal product based on an amino oxazolinone derivative, intended, in particular, for the treatment of asthenia.
FR6247M (en) New therapeutic applications of 2,3-epithioids.
FR2012M (en) Medicinal product based on a new heptapeptide.
FR1295832A (en) Process for preparing peptide derivatives, in particular peptide hydrazides
DK105400C (en) Process for the preparation of dimeric 1,4-bis- (cyclopentadienyl) -butene-2.
FR1891M (en) Medicinal product based on a phenoxy-alkane.
FR2410M (en) Medicinal product based on oxazine derivative.
FR79810E (en) Shoe repair device, in particular for pre-molding and stamping the backs of shoe uppers
FR2551M (en) Medicinal product based on (+) 5-phenyl-2-amino oxazolinone-4 intended in particular for the treatment of asthenia.
FR1249M (en) Medicinal product based on n- (2,3,5,6-tetrachlorophenyl) anthranilic acid, in particular for treating inflammatory conditions.
FR1203223A (en) Shoe repair device, in particular for pre-molding and stamping the backs of shoe uppers
FR1143M (en) Medicinal product based on a pyimidic derivative, in particular for the treatment of hypercholesterolemia and hyper-uricemia.
FR1180M (en) Medicinal product based on a derivative of uracyl, intended in particular for the treatment of hyperuricemia and hypercholesterolemia.
FR2027M (en) Dietetic product calming the appetite.
FR3323M (en) Medicinal product based on aza-thiaxanthene derivative.
FR1743M (en) Medicinal product based on hydroxylamine derivatives.
FR1037M (en) Drug intended for the treatment of aerocolies, meteorism and gastralgia.
FR2161M (en) Medicinal product based on hydrazine derivative.
FR78289E (en) Shoe repair device, in particular for pre-molding and stamping the backs of shoe uppers
FR81329E (en) Shoe repair device, in particular for pre-molding and stamping the backs of shoe uppers
FR1174M (en) Medicinal product based on bismuth and sulfanilamide complexes, in particular for the treatment of tonsillitis.
FR1144M (en) Medicinal product based on 1.2-diaryl-3.5-dioxo-pyrazolidines.